DKK3 and central nervous system cancer: The actual mechanism by which DKK3 acts inhibitory on Wnt pathway activation has not been identified yet, but suppression of DKK3 increased β-catenin/T-cell factor (TCF)-dependent gene activity in mammary cells [39], cancerous lung cells [40] and glioma [41].